The Anti-Hepatitis B Drug Entecavir Inhibits HIV-1 Replication and Can Select HIV-1 Variants Resistant to Antiretroviral Drugs

We show that entecavir, an FDA-approved drug used to treat chronic hepatitis B, potently inhibits HIV replication in vitro and leads to a 1 log decline in HIV RNA in vivo. Detailed analysis of two HIV-HBV co-infected patients receiving up to seven months of entecavir monotherapy demonstrated accumul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: McMahon, Moira A., Jilek, Benjamin L., Brennan, Timothy P., Shen, Lin, Zhou, Yan, Wind-Rotolo, Megan, Xing, Sifei, Bhat, Shridhar, Hale, Braden, Hegarty, Robert, Chong, Curtis R., Liu, Jun O., Siliciano, Robert F., Thio, Chloe L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2007
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3069686/
https://ncbi.nlm.nih.gov/pubmed/17582071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa067710
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge